Vitamin D levels and perinatal anxiety in an anxiety-focused behavioral intervention program in Pakistan
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
PURPOSE: This study investigates Vitamin D levels across the perinatal period and relationships with perinatal anxiety and immune markers in women in Pakistan. METHODS: We analyzed plasma levels of 25-hydroxyvitamin D and cytokines and chemokines from 117 participants from the "Happy Mother-Healthy Baby" trial, which evaluated a non-specialist delivered cognitive behavioral therapy intervention for perinatal anxiety. Blood samples were collected at four timepoints: T1 (10-22 weeks), T2 (22-26 weeks), T3 (34-38 weeks), and T4 (six weeks postpartum). Participants were categorized into anxiety groups using K-means clustering. Mixed-effect models were used to examine Vitamin D trajectories, and moderation analysis explored the impact of immune markers on the Vitamin D-anxiety relationship. RESULTS: Vitamin D levels were severely deficient across all timepoints (< 5 ng/ml) and declined significantly from T1 to T2 (β = -0.549, p = .006) before rebounding postpartum (β = 1.492, p < .0001). Despite this widespread Vitamin D deficiency, no significant differences in Vitamin D trajectories were observed across anxiety groups. Higher innate immune activity correlated with higher Vitamin D levels at T1. IL-6 and CXCL-8 levels moderated the Vitamin D and anxiety relationship at T2 (IL-6: β = 2.98, p = .015; CXCL-8: β = 0.72, p = .030); among those with higher levels of IL-6 and CXCL-8, higher Vitamin D levels were associated with higher levels of anxiety. CONCLUSIONS: These findings indicate the need for further research on maternal Vitamin D deficiency and its relationship with immune function in low- and middle-income countries.